Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2440]

ASCO 2015: Pembrolizumab may be promising treatment for urothelial cancer

ASCO 2015: Pembrolizumab may be promising treatment for urothelial cancer

Western diet after prostate cancer diagnosis associated with increased risk of death

Western diet after prostate cancer diagnosis associated with increased risk of death

ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer

ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer

ASCO 2015: Genomic marker predicts anti-PD-1 response in several cancers

ASCO 2015: Genomic marker predicts anti-PD-1 response in several cancers

Increasing body mass index linked with worse localised prostate cancer outcomes

Increasing body mass index linked with worse localised prostate cancer outcomes

ASCO 2015: Adding chemotherapy to initial therapy extends lives of men with advanced, hormone-naïve prostate cancer

ASCO 2015: Adding chemotherapy to initial therapy extends lives of men with advanced, hormone-naïve prostate cancer

MRI - prostate cancer screening for the future?

MRI - prostate cancer screening for the future?

UK's first proton beam therapy centres will 'transform' cancer care treating more than 2000 patients per year

UK's first proton beam therapy centres will 'transform' cancer care treating more than 2000 patients per year

Unemployment linked to rise in prostate cancer deaths

Unemployment linked to rise in prostate cancer deaths

Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after five years

Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after...

More from ecancer